J7185Drugs Administered Other than Oral Method

Injection, factor viii (antihemophilic factor, recombinant) (xyntha), per i.u.

Short description: Xyntha inj

Effective date: January 1, 2010
Termination date: —

Related codes (J-series)

J0013Esketamine, nasal spray J0014Cocaine hcl nasal (goprelto)J0120Tetracyclin injection J0121Inj., omadacycline, 1 mg J0122Inj., eravacycline, 1 mg J0129Abatacept injection J0130Abciximab injection J0131Inj, acetaminophen (nos)J0132Acetylcysteine injection J0133Acyclovir injection J0134Inj acetaminophen -fresenius J0135Adalimumab injection

Frequently asked questions

What is HCPCS code J7185?

J7185 is a HCPCS Level II code for Injection, factor viii (antihemophilic factor, recombinant) (xyntha), per i.u..

What category is HCPCS code J7185 in?

J7185 falls under the Drugs Administered Other than Oral Method category of HCPCS Level II.

When did HCPCS code J7185 become effective?

J7185 has been effective since January 1, 2010, per CMS's quarterly HCPCS update.

HCPCS Level II data from CMS (public domain). HCPCS Level I (CPT) codes are not included — CPT is copyrighted by the American Medical Association. Always verify codes with authoritative sources before making coding or billing decisions.